fig7

Figure 7. Flow cytometry of CD3+T cells, B cells, NK cells, DC cells, and macrophages. (A) Flow cytometry gating strategy for cutaneous lymphoid subsets; (B) Changes in the proportions of T cells, B cells, NK cells, DC cells, and macrophages in the spleen in models treated with PBS, 0.5 × 10⁸ Exosomes, 1 × 10⁸ Exosomes, 1.5 × 10⁸ Exosomes, and ASCs; (C) Changes in the proportions of T cells, B cells, NK cells, DC cells, and macrophages in the blood in models treated with PBS, 0.5 × 10⁸ Exosomes, 1 × 10⁸ Exosomes, 1.5 × 10⁸ Exosomes, and ASCs; (D) Changes in the proportions of T cells, B cells, NK cells, DC cells, and macrophages in the dLN in models treated with PBS, 0.5 × 10⁸ Exosomes, 1 × 10⁸ Exosomes, 1.5 × 10⁸ Exosomes, and ASCs. DCs: Dendritic cells; NK cells: natural killer cell; ASCs: adipose-derived stem cells. ^*P < 0.05; ^**P < 0.01; ^***P < 0.001; ^****P < 0.0001.